- Home
- Equipment
- north korea
- inflammatory immune
Refine by
Inflammatory Immune Equipment & Supplies In North Korea
14 equipment items found
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-572 is a broad-spectrum serine beta-lactamase inhibitor (BLI) of the diazabicyclooctane (DBO) ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-421 is a highly selective, brain penetrant RIPK1 ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-475 potently inhibits multiple clinically validated pathways (IL-12/IL-23-p40, Th17 cytokines and TNF) relevant to psoriasis pathophysiology. BOS-475 demonstrates broad inhibitory activities on other key disease-relevant immune-inflammatory mediators such as MCP-1, IL-6, and CXCL10 & 11. Topical BOS-475 is a potential treatment for psoriasis and other ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-228 is a novel monobactam for infections caused by multidrug-resistant carbapenem-resistant ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS161721 (avizakimab) is a fully human anti-IL-21 ...
Manufactured by:Foreverest Resources Ltd. based inXiamen, CHINA
For feed additive formulation, Myrcene has the properties of bacteriostasis, anti-inflammatory, immunity regulation, ...
Manufactured by:Foreverest Resources Ltd. based inXiamen, CHINA
For feed additive formulation, turpentine oil has the properties of anti-inflammatory and immunity ...
Manufactured by:Nano Intelligent Biomedical Engineering Corporations (NIBEC) Co., Ltd. based inJincheon-gun, SOUTH KOREA
Manufactured by removing organic components and purifying only inorganic bone mineral, OCS-H has a low rate of inflammation and immune rejection. It is a biocompatible bone graft material that is made from equine bone, of which structure is almost the same as human bone, so that it can be easily compatible with surrounding bone tissue when grafted. OCS-H bone graft material is ...
by:Algae Products International Ltd based inClydach, UNITED KINGDOM
With its striking red-orange hue and an array of potential health benefits, Astaxanthin offers a world of possibilities. Experience its remarkable anti-inflammatory properties, immune-boosting effects, and potential contributions to eye health, skin rejuvenation, cardiovascular wellness, and enhanced exercise performance. As a highly sought-after ingredient, ...
Manufactured by:Enterome based inParis, FRANCE
EB1010 is an orally administered, GI-selective next generation IL-10 inducer designed to induce high local secretion of IL-10 for the treatment of Inflammatory Bowel Disease (IBD) and food allergy. EB1010 is a peptide that modulates the immune system by closely mimicking effects of a specific class of hormones. IL-10 deficiency is central to ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES002’s dual ATP-adenosine mechanism is a potentially powerful TME regulator and transformative cancer immunotherapy. In preclinical studies ES002 demonstrated significant single agent anti-tumor activity as well as an excellent tolerability profile. ES002 has also shown superior enzymatic inhibition and binding ...
Manufactured by:Nano Intelligent Biomedical Engineering Corporations (NIBEC) Co., Ltd. based inJincheon-gun, SOUTH KOREA
OCS-B Xenomatrix bone graft material is bone mineral derived from bovine bone. Inflammatory organic components have been completely removed by rigorous manufacturing processes, and the structure of OCS-B Xenomatrix has a high resemblance to that of human bone. Helping osteoblasts facilitate smooth bone matrix synthesis and bone calcification, OCS-B Xenomatrix significantly promotes reconstruction ...
Manufactured by:Regeneus Ltd. based inPaddington, AUSTRALIA
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic). ...
Manufactured by:Firalis Group based inHuningue, FRANCE
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...